Healthtech Startups

PeerFit (operating as FitOn Health) provides digital fitness and wellness content via an app, combined with access to a national network of in-person fitness experiences, targeting corporate employers seeking employee health and wellness programs.

3 investors

Pelage develops regenerative medicines for hair loss based on stem cell biology, with a lead candidate (PP405) that is a topical small-molecule drug designed to reactivate dormant hair follicle stem cells. It targets conditions including androgenetic alopecia, drug-induced alopecia, and telogen effluvium, and is currently in clinical trials.

3 investors

PeopleOne Health is a value-based primary care provider offering physical and mental health prevention and treatment services through employer-funded health centers. It serves employers, brokers, and their employees with primary care that reduces healthcare costs and eliminates member copays, deductibles, and coinsurance.

3 investors

PepGen is a clinical-stage biotech company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide (EDO) platform to improve tissue penetration and uptake in muscle tissues.

3 investors

Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials. It operates in oncology drug development, with its research group linked to the Vall d'Hebron Institute of Oncology in Barcelona, Spain.

3 investors

Perceptive Medical develops the BaroHawk Vasopressor Management System, an FDA-designated breakthrough device for automated blood pressure control during surgery and intensive care. It is aimed at clinicians managing patients in operating rooms and ICUs to reduce episodes of low blood pressure and lower provider workload.

3 investors

Peregrine Health partners with Federally Qualified Health Centers (FQHCs) to design, manage, and operate behavioral health service lines by placing licensed clinicians, handling program operations, and providing a technology platform for scheduling and outcome tracking. It serves community health centers addressing mental health and substance use care, offering programs such as Behavioral Health Integration and Medication-Assisted Treatment.

3 investors

Pet Friendly Direct offers personalized pet wellness products including flea and tick solutions, treats, supplements, and other pet care items for dog and cat owners.

3 investors

PetaGene develops PetaSuite, Linux software that losslessly compresses genomic data files (BAM and FASTQ.gz) by 60-90% while allowing tools to access files in their original format via on-the-fly decompression, both on-premises and in the cloud. It serves genomics research organizations, hospitals, and life sciences institutions to reduce storage costs and data transfer times.

3 investors

Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma. The system is designed for patients, clinicians, and hospitals as an alternative to conventional and robotic surgery.

3 investors

PFx Biotech develops alternative protein products aimed at meeting high nutritional standards and offering health-promoting properties. The company operates in the alternative protein and biotech space.

3 investors

Phagenesis develops targeted pharyngeal electrical stimulation technology to treat neurogenic dysphagia by restoring neural pathways for safe swallowing. The company serves patients with swallowing disorders caused by neurological conditions, supported by 25 years of clinical research and evidence.

3 investors

CCX offers an enterprise platform for market access, contract management, and pricing aimed at global pharmaceutical companies and payers. The software lets users plan, model, and analyze contract scenarios and coordinate contract administration between pharma and payers.

3 investors

PharmaJet develops needle-free injection systems for delivering vaccines and therapeutics, used across a range of therapeutic areas including infectious disease prevention and cancer treatment. Its reusable devices serve pharmaceutical partners and healthcare providers as an alternative to traditional needle-based delivery.

3 investors

Pharmaron is a contract research and manufacturing organization providing drug development and manufacturing services to pharmaceutical and biotech companies.

3 investors

PharmaX designs digital healthcare solutions focused on improving access to medical services and medications for patients in Japan. The company uses technology to reduce barriers to healthcare and provide continuous patient support through digital consultation and AI-driven health management.

3 investors

Advance Canadian Pharmacy is an online pharmacy selling prescription and over-the-counter medications, generics, and skincare products across more than 20 categories, with a focus on lower-cost generics and prescription fulfillment. It serves consumers, largely in the United States, sourcing through licensed Canadian and international pharmacies and offering delivery, compounding, and prescription services.

3 investors

Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity. It serves academic and research institutions and biopharmaceutical firms across life sciences, medicine, and agriculture.

3 investors

Phase Zero builds an AI copilot for clinical registry teams that extracts and abstracts data points from clinical documentation such as EMS run sheets and pathology reports, helping registrars find cases and complete abstractions. It also matches cases to clinical guidelines, detects treatment variances, and flags improvement opportunities for quality and compliance workflows.

3 investors

Phases provides AI-powered oversight for clinical trials, using automated agents to detect operational issues, maintain data standards, and ensure regulatory compliance without manual intervention.

3 investors

Phathom Pharmaceuticals is a pharmaceutical company that develops and markets prescription treatments, including VOQUEZNA (vonoprazan) for gastrointestinal conditions, in the U.S. market.

3 investors

Phiex Technologies develops interactive materials designed to mitigate issues caused by pathogens across multiple industries, including applications such as making sterile devices and protecting individuals exposed to the elements. The company offers this material technology without requiring machines or chambers.

3 investors

Philduct is a Japanese oral-tech company that develops DPEARL, a 3D-printed clear aligner orthodontic service, along with remote dental consultation and digital dentistry services. It operates a dental technology R&D lab and targets consumers seeking affordable preventive oral healthcare in Japan.

3 investors

Phoebe is an applied AI company based in New York City that works to bring AI into real-world applications.

3 investors